Skip to main content
SpringerLink
Log in

Maraviroc/raltegravir

Cholestasis, elevated liver enzymes and peripheral neuropathy: 3 case reports

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Mangiafico L, Perja M, Fusco F, Riva S, Mago D, Gringeri A.Safety and effectiveness of raltegravir in patients with haemophilia and anti-HIV multidrug resistance. Haemophilia 18: 108-11, No. 1, Jan 2012. Available from: URL: http://dx.doi.org/10.1111/j.1365-2516.2011.02610.x - Italy

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Maraviroc/raltegravir. React. Wkly. 1403, 24 (2012). https://doi.org/10.2165/00128415-201214030-00079

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-201214030-00079

Keywords

Search

Navigation